See more : Bone Therapeutics SA (BOTHE.BR) Income Statement Analysis – Financial Results
Complete financial analysis of Oxbridge Acquisition Corp. (OXACW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oxbridge Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Investeringsforeningen Portfoliomanager Lundgreen’s Capital – China, Kl (PMILGICHIEUR.CO) Income Statement Analysis – Financial Results
- RF Capital Group Inc. (GMPXF) Income Statement Analysis – Financial Results
- Aarti Pharmalabs Limited (AARTIPHARM.NS) Income Statement Analysis – Financial Results
- Pacific CMA, Inc. (PACC) Income Statement Analysis – Financial Results
- CR Construction Group Holdings Limited (1582.HK) Income Statement Analysis – Financial Results
Oxbridge Acquisition Corp. (OXACW)
Industry: Shell Companies
Sector: Financial Services
About Oxbridge Acquisition Corp.
Oxbridge Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify a target in the disruptive technology market. The company was incorporated in 2021 and is based in Georgetown, Cayman Islands.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 12.21M | 21.86M | 1.11M |
| Cost of Revenue | 12.39M | 19.80M | 1.38M |
| Gross Profit | -178.53K | 2.06M | -270.91K |
| Gross Profit Ratio | -1.46% | 9.42% | -24.36% |
| Research & Development | 160.86K | 137.28K | 117.39K |
| General & Administrative | 11.60M | 9.23M | 14.88M |
| Selling & Marketing | 573.88K | 426.73K | 704.72K |
| SG&A | 12.17M | 9.66M | 15.58M |
| Other Expenses | 0.00 | 3.00 | 207.37K |
| Operating Expenses | 12.33M | 9.79M | 15.70M |
| Cost & Expenses | 24.73M | 29.60M | 17.08M |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 103.62K | 0.00 | 0.00 |
| Depreciation & Amortization | 135.25K | 134.38K | 133.61K |
| EBITDA | -12.38M | -7.60M | -15.84M |
| EBITDA Ratio | -101.31% | -34.77% | -1,424.12% |
| Operating Income | -12.51M | -7.74M | -15.97M |
| Operating Income Ratio | -102.42% | -35.38% | -1,436.13% |
| Total Other Income/Expenses | -103.50K | 3.00 | 207.37K |
| Income Before Tax | -12.61M | -7.74M | -15.77M |
| Income Before Tax Ratio | -103.27% | -35.38% | -1,417.49% |
| Income Tax Expense | 2.46K | 2.40K | -102.95K |
| Net Income | -12.62M | -7.74M | -15.77M |
| Net Income Ratio | -103.29% | -35.39% | -1,417.49% |
| EPS | -2.00 | -0.89 | -1.81 |
| EPS Diluted | -2.00 | -0.89 | -1.81 |
| Weighted Avg Shares Out | 6.33M | 8.72M | 8.72M |
| Weighted Avg Shares Out (Dil) | 6.33M | 8.72M | 8.72M |
Source: https://incomestatements.info
Category: Stock Reports